Financials · financial year 2025, full format
Annual accounts 2025 filed on 02-06-2026 PDF all 50 filings
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result for 2025 is 58% lower than in 2024 and the lowest since 2021.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Wholesale trade (NACE 46). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
Comparable companies
These companies have the same main activity as Pfizer: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €128m and €590m, founded between 1960 and 1989.
| Company | Founded | Total assets | Equity | Turnover | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| Pfizer Elsene | 1954 | €377.4m | - | €358.3m | €3.7m | 297 | 2025 |
| Danone Belux Brussel | 1960 | €140.6m | €21.8m | €326.9m | €9.3m | 374.3 | 2025 |
| Terumo BCT Europe Zaventem | 1973 | €590.3m | €515.9m | €369.5m | €59.1m | 271 | 2026 |
| MSD BELGIUM Watermaal-Bosvoorde | 1969 | €150.3m | €42.4m | €506.5m | €13.6m | 171.5 | 2025 |
| CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE Anderlecht | 1968 | €127.7m | €11.6m | €580.7m | -€0.3m | 243.9 | 2025 |
| ANSELL HEALTHCARE EUROPE Anderlecht | 1989 | €400.0m | €93.5m | €472.7m | €66.9m | 209.5 | 2025 |
| JOHNSON & JOHNSON MEDICAL Machelen (Brab.) | 1984 | €225.6m | €80.2m | €330.0m | €10.2m | 267.5 | 2025 |
They were chosen from the 1,134 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Subsidies and aid
European research
1 projectPublic contracts
Show 45 more contracts
The 50 most recent of 54 awards.
Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Operating income70/76A | €222.9m | €282.6m | €317.3m | €543.0m | €632.9m | €413.6m | €392.6m | €414.1m | ▲ 5.5% |
| Turnover70 | €148.7m | €220.6m | €240.2m | €469.5m | €548.2m | €349.4m | €336.5m | €358.3m | ▲ 6.5% |
| Other operating income74 | €74.2m | €62.0m | €77.1m | €71.9m | €84.7m | €64.2m | €56.1m | €55.8m | ▼ 0.6% |
| Non-recurring operating income76A | - | - | - | €1.6m | - | - | - | - | - |
| Operating charges60/66A | €210.8m | €270.2m | €302.6m | €515.9m | €603.1m | €392.9m | €356.3m | €399.0m | ▲ 12.0% |
| Goods for resale, raw materials and consumables60 | €113.3m | €156.6m | €196.4m | €401.7m | €467.8m | €275.1m | €222.0m | €274.6m | ▲ 23.7% |
| Change in stocks: decrease (increase)609 | -€5.9m | -€21.5m | -€0.2m | €3.8m | -€40.0m | -€42.2m | -€23.7m | €17.3m | - |
| Services and other goods61 | €41.1m | €46.3m | €44.4m | €44.4m | €47.0m | €42.9m | €36.9m | €34.7m | ▼ 6.0% |
| Remuneration, social security and pensions62 | €41.1m | €48.5m | €50.9m | €56.5m | €66.1m | €64.9m | €76.4m | €53.9m | ▼ 29.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1.7m | €3.0m | €1.1m | €1.2m | €1.1m | €1.0m | €1.0m | €1.0m | ▼ 3.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | -€0.4m | €1.2m | €3.2m | -€1.8m | -€0.3m | €2.9m | €5.8m | -€4.4m | - |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €2.2m | -€1.2m | €0.2m | €1.1m | €7.8m | -€7.0m | -€2.3m | €18.4m | - |
| Other operating charges640/8 | €11.9m | €15.8m | €6.3m | €12.8m | €13.5m | €13.2m | €16.5m | €20.8m | ▲ 26.1% |
| Operating profit (loss)9901 | €12.1m | €12.5m | €14.7m | €27.1m | €29.8m | €20.7m | €36.2m | €15.1m | ▼ 58.2% |
| Recurring financial income75 | €0.4m | €0.6m | €0.2m | €0.2m | €0.8m | €1.2m | €1.3m | €1.3m | ▼ 1.7% |
| Income from current assets751 | - | - | €0.01m | €0.01m | €0.1m | €0.7m | €1.1m | €0.7m | ▼ 31.0% |
| Other financial income752/9 | €0.4m | €0.6m | €0.2m | €0.2m | €0.7m | €0.4m | €0.3m | €0.6m | ▲ 124% |
| Financial charges65/66B | €0.5m | €0.8m | €0.3m | €0.3m | €1.0m | €3.8m | €4.9m | €3.7m | ▼ 25.4% |
| Recurring financial charges65 | €0.5m | €0.8m | €0.3m | €0.3m | €1.0m | €3.8m | €4.9m | €3.7m | ▼ 25.4% |
| Debt charges650 | - | - | €306 | €0.1m | €0.3m | €3.3m | €4.3m | €2.8m | ▼ 34.3% |
| Other financial charges652/9 | €0.5m | €0.8m | €0.3m | €0.2m | €0.7m | €0.5m | €0.6m | €0.8m | ▲ 43.5% |
| Profit (loss) for the period before taxes9903 | €11.9m | €12.3m | €14.6m | €27.0m | €29.6m | €18.0m | €32.6m | €12.8m | ▼ 60.8% |
| Income taxes67/77 | €3.9m | €3.0m | €5.0m | €7.5m | €8.0m | €5.1m | €9.5m | €9.1m | ▼ 3.5% |
| Taxes670/3 | €4.0m | €3.0m | €5.0m | €7.5m | €8.1m | €5.1m | €9.5m | €9.1m | ▼ 3.5% |
| Tax adjustments and reversals of tax provisions77 | €0.06m | - | €0.001m | €0.009m | €0.1m | - | - | - | - |
| Profit (loss) for the period9904 | €8.0m | €9.4m | €9.7m | €19.5m | €21.6m | €12.9m | €23.2m | €3.7m | ▼ 84.2% |
| Profit (loss) for the period to be appropriated9905 | €8.0m | €9.4m | €9.7m | €19.5m | €21.6m | €12.9m | €23.2m | €3.7m | ▼ 84.2% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €166.9m | €283.8m | €194.2m | €254.7m | €285.3m | €383.4m | €474.6m | €377.4m | ▼ 20.5% |
| Fixed assets21/28 | €9.0m | €12.0m | €10.9m | €10.1m | €11.2m | €11.1m | €10.1m | €11.4m | ▲ 12.9% |
| Intangible fixed assets21 | €0.6m | - | - | - | - | - | - | - | - |
| Tangible fixed assets22/27 | €7.8m | €6.9m | €6.1m | €5.3m | €6.4m | €6.0m | €5.1m | €6.4m | ▲ 25.5% |
| Plant, machinery and equipment23 | €1.1m | €0.9m | €0.8m | €0.8m | €0.7m | €0.7m | €0.5m | €0.4m | ▼ 23.4% |
| Furniture and vehicles24 | €0.9m | €0.7m | €0.5m | €0.3m | €0.6m | €0.6m | €0.9m | €0.7m | ▼ 24.8% |
| Other tangible fixed assets26 | €5.8m | €5.2m | €4.7m | €4.1m | €4.3m | €4.1m | €3.5m | €3.0m | ▼ 15.6% |
| Assets under construction and advance payments27 | €0.006m | €0.2m | €0.1m | €0.08m | €0.8m | €0.6m | €0.09m | €2.3m | ▲ 26× |
| Financial fixed assets28 | €0.5m | €5.1m | €4.8m | €4.8m | €4.8m | €5.1m | €5.1m | €5.1m | ▲ 0.3% |
| Affiliated companies280/1 | €26 | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | = |
| Participating interests280 | €26 | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | €4.2m | = |
| Other financial fixed assets284/8 | €0.5m | €0.9m | €0.6m | €0.5m | €0.6m | €0.8m | €0.8m | €0.8m | ▲ 1.8% |
| Amounts receivable and cash guarantees285/8 | €0.5m | €0.9m | €0.6m | €0.5m | €0.6m | €0.8m | €0.8m | €0.8m | ▲ 1.8% |
| Current assets29/58 | €158.0m | €271.7m | €183.2m | €244.6m | €274.0m | €372.3m | €464.5m | €365.9m | ▼ 21.2% |
| Stocks and contracts in progress3 | €60.0m | €95.4m | €92.5m | €90.4m | €130.7m | €170.1m | €188.0m | €175.1m | ▼ 6.9% |
| Stocks30/36 | €60.0m | €95.4m | €92.5m | €90.4m | €130.7m | €170.1m | €188.0m | €175.1m | ▼ 6.9% |
| Goods purchased for resale34 | €60.0m | €95.4m | €92.5m | €90.4m | €130.7m | €170.1m | €188.0m | €175.1m | ▼ 6.9% |
| Amounts receivable within one year40/41 | €75.2m | €83.0m | €79.9m | €111.3m | €142.4m | €179.8m | €165.6m | €166.0m | ▲ 0.2% |
| Trade receivables40 | €73.1m | €80.9m | €74.2m | €109.6m | €136.3m | €171.0m | €161.0m | €123.7m | ▼ 23.2% |
| Other amounts receivable41 | €2.1m | €2.1m | €5.8m | €1.7m | €6.1m | €8.8m | €4.6m | €42.3m | ▲ 823% |
| Current investments50/53 | - | - | €381 | - | - | €0.06m | €87.1m | €0.02m | ▼ 100.0% |
| Other investments51/53 | - | - | €381 | - | - | €0.06m | €87.1m | €0.02m | ▼ 100.0% |
| Cash at bank and in hand54/58 | €21.2m | €90.5m | €8.8m | €40.7m | €0.7m | €21.9m | €21.3m | €23.9m | ▲ 12.1% |
| Deferred charges and accrued income490/1 | €1.5m | €2.9m | €2.0m | €2.2m | €0.2m | €0.4m | €2.5m | €0.9m | ▼ 63.8% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €166.9m | €283.8m | €194.2m | €254.7m | €285.3m | €383.4m | €474.6m | €377.4m | ▼ 20.5% |
| Equity10/15 | €89.8m | €139.7m | €99.3m | €118.8m | €90.4m | - | - | - | - |
| Contributions10/11 | €28.9m | €39.7m | €40.8m | €40.8m | €40.8m | €40.8m | €40.8m | €40.8m | = |
| Capital10 | €28.9m | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | = |
| Issued capital100 | €28.9m | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | €39.7m | = |
| Contributions outside capital11 | €0.8m | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | = |
| Share premium1100/10 | - | - | - | €1.1m | €1.1m | €1.1m | €1.1m | €1.1m | = |
| Reserves13 | €5.9m | €8.0m | €8.0m | €8.0m | €8.0m | €8.0m | €8.0m | €8.0m | = |
| Non-distributable reserves130/1 | - | - | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | = |
| Legal reserve130 | €2.9m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | = |
| Reserves not available under the articles1311 | €0.02m | €0.02m | - | - | - | - | - | - | - |
| Other1319 | - | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Tax-exempt reserves132 | €2.9m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | €4.0m | = |
| Distributable reserves133 | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | = |
| Profit (loss) carried forward14 | €54.2m | €90.8m | €50.5m | €70.0m | €41.6m | €54.5m | €77.7m | €81.4m | ▲ 4.7% |
| Provisions and deferred taxes16 | €3.5m | €2.3m | €2.5m | €3.6m | €11.4m | - | - | - | - |
| Provisions for liabilities and charges160/5 | €3.5m | €2.3m | €2.5m | €3.6m | €11.4m | €4.4m | €2.1m | €20.5m | ▲ 876% |
| Pensions and similar obligations160 | - | - | - | - | €3.7m | - | - | - | - |
| Other liabilities and charges164/5 | €3.5m | €2.3m | €2.5m | €3.6m | €7.6m | €4.4m | €2.1m | €20.5m | ▲ 876% |
| Amounts payable17/49 | €73.7m | €141.8m | €92.3m | €132.2m | €183.5m | €275.7m | €346.0m | €226.6m | ▼ 34.5% |
| Amounts payable within one year42/48 | €70.3m | €135.2m | €89.2m | €130.1m | €182.6m | €249.2m | €338.4m | €224.7m | ▼ 33.6% |
| Financial debts43 | - | - | - | - | €81.3m | €146.6m | €0.02m | €162.9m | ▲ 6,663× |
| Credit institutions430/8 | - | - | - | - | - | - | €0.02m | €0.8m | ▲ 34× |
| Other loans439 | - | - | - | - | €81.3m | €146.6m | - | €162.0m | - |
| Trade debts44 | €18.4m | €63.3m | €27.3m | €66.4m | €26.4m | €5.9m | €75.9m | €34.0m | ▼ 55.1% |
| Suppliers440/4 | €18.4m | €63.3m | €27.3m | €66.4m | €26.4m | €5.9m | €75.9m | €34.0m | ▼ 55.1% |
| Taxes, remuneration and social security45 | €52.0m | €71.9m | €61.9m | €63.7m | €75.0m | €76.4m | €255.6m | €23.3m | ▼ 90.9% |
| Taxes450/3 | €40.8m | €58.8m | €49.1m | €46.9m | €52.4m | €60.9m | €237.6m | €7.0m | ▼ 97.1% |
| Remuneration and social security454/9 | €11.2m | €13.2m | €12.8m | €16.8m | €22.5m | €15.6m | €18.0m | €16.3m | ▼ 9.3% |
| Other amounts payable47/48 | - | - | - | €0.02m | - | €20.3m | €6.9m | €4.5m | ▼ 35.0% |
| Accrued charges and deferred income492/3 | €3.4m | €6.6m | €3.1m | €2.1m | €0.8m | €26.5m | €7.7m | €1.9m | ▼ 74.7% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €8.0m | €9.4m | €9.7m | €19.5m | €21.6m | €12.9m | €23.2m | €3.7m | ▼ 84.2% |
| + Depreciation and write-downs630 | €1.7m | €3.0m | €1.1m | €1.2m | €1.1m | €1.0m | €1.0m | €1.0m | ▼ 3.4% |
| Operating cash flow (approximation) | €9.7m | €12.3m | €10.8m | €20.7m | €22.7m | €13.9m | €24.2m | €4.7m | ▼ 80.7% |
| Investment in fixed assets (approximation) | - | -€6.0m | -€0.05m | -€0.3m | -€2.3m | -€0.8m | -€0.09m | -€2.3m | ▼ 2,470% |
| Change in cash | - | €69.3m | -€81.7m | €31.9m | -€40.0m | €21.2m | -€0.6m | €2.6m | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 50 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 30-11-2025 | full format | 02-06-2026 | 2026-00137670 | |
| 30-11-2024 | full format | 23-05-2025 | 2025-00110685 | |
| 30-11-2023 | full format | 21-05-2024 | 2024-00094385 | |
| 30-11-2022 | full format | 23-05-2023 | 2023-00098666 | |
| 30-11-2021 | full format | 01-06-2022 | 2022-20046669 | |
| 30-11-2020 | full format | 31-05-2021 | 2021-16800407 | |
| 30-11-2019 | full format | 29-06-2020 | 2020-22200444 | |
| 30-11-2018 | full format | 22-05-2019 | 2019-14500482 | |
| 30-11-2017 | full format | 30-05-2018 | 2018-15300114 | |
| 30-11-2016 | full format | 09-06-2017 | 2017-16800333 |